Malaria elimination strategies focus on reducing transmission of Plasmodium parasites through integrated approaches such as widespread distribution of insecticide-treated bed nets, indoor residual spraying, rapid diagnostic testing, and effective antimalarial treatments. Recent advancements include gene-drive mosquito control, vaccine deployment, and digital surveillance systems to track outbreaks in real time. Global efforts emphasize targeted interventions in high-burden regions, cross-border collaborations, and sustained funding to achieve the long-term goal of zero malaria.
Market Analysis: In 2025, the global malaria elimination market—which includes diagnostics, vector control, vaccines, and therapeutics—is valued at approximately USD 4.6 billion. With continued investments from governments, NGOs, and international health organizations, the market is projected to reach USD 7.5 billion by 2030, growing at a CAGR of 10.2%. Africa remains the largest market due to the highest disease burden, while Asia-Pacific shows significant growth potential through government-backed eradication programs. Increased adoption of digital health tools and novel vaccine technologies is expected to drive future expansion.
